Family behind Purdue Pharma to face congressional scrutiny
Members of the family who own OxyContin maker Purdue Pharma are scheduled to make a rare appearance Thursday in a public forum, answering questions from a congressional panel about their role in the nation's long-running opioid addiction crisis.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
